Is it the Right Time to Hold EW Stock in Your Portfolio Now?
Edward Lifesciences Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.…
69,650€
2,31%
Echtzeit-Aktienkurs Edwards Lifesciences Corp.
Bid:
Ask:
Nachrichten zur Edwards Lifesciences Corp. Aktie
Edwards Lifesciences Aktie: Leichter Rückgang trotz solider Aussichten
Die Edwards Lifesciences Aktie verzeichnete am 21. September 2024 einen leichten Rückgang von 0,57% auf 66,84 USD. Trotz dieses kleinen…
Edwards Lifesciences: Solvable Problems Offer Excellent Opportunities
…
BD Stock Falls After Acquisition of Edwards Critical Care Group
BDX expands its smart care portfolio by acquiring Edwards Lifesciences Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven…
Should You Hold Edward Lifesciences (EW) in Your Portfolio Now?
Edward Lifesciences (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.…
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.…
After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more By Investing.com
After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more…
Edwards Lifesciences Crumbles On Slashed TAVR Outlook
The company now expects full-year sales in its TAVR division to climb 5% to 7%.…
Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions
Edwards Lifesciences (EW) exercises the option to acquire Innovalve Bio-Medical Ltd., strengthening its TMVR technology portfolio and addressing unmet…
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
Edwards Lifesciences (EW) TMTT segments PASCAL platform is likely to have maintained strong growth momentum in the second quarter…
Edwards Lifesciences: Focus On The Heart
…
Aktienmarkt: Edwards Lifesciences-Aktie tritt auf der Stelle (85,6517 €)
Wenig Kursbewegung aktuell bei dem Anteilsschein von Edwards Lifesciences . Das Papier kostete zuletzt 91,47 US-Dollar. Die Wertschätzung der Investoren…
Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
…
Edwards Lifesciences Stock Jumps On Surprise $4.2 Billion Deal
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinsons plan to buy a key division for $4.2 billion.…
Edwards Lifesciences exec sells shares worth over $73k By Investing.com
Edwards Lifesciences exec sells shares worth over $73k…
Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
…
The Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.…
Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance By Investing.com
Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance…
Edwards Lifesciences stock maintains $100 target and Buy rating By Investing.com
Edwards Lifesciences stock maintains $100 target and Buy rating…
Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry…
Edwards Lifesciences exec sells over $1.1m in company stock By Investing.com
Edwards Lifesciences exec sells over $1.1m in company stock…
Edwards Lifesciences executive sells over $2.7 million in stock By Investing.com
Edwards Lifesciences executive sells over $2.7 million in stock…
Edwards Lifesciences Corporations (NYSE:EW) Stock Is Going Strong: Is the Market Following Fundamentals?
Edwards Lifesciences (NYSE:EW) has had a great run on the share market with its stock up by a significant 23%…
Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook By Investing.com
Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook…
Edwards Lifesciences (EW) Hits 52-Week High: Whats Driving It?
Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in…
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Shares of Edwards Lifesciences Corp. rose 2.22% to $92.93 Wednesday, on what proved to be an all-around mixed trading session…
Edwards Lifesciences (EW) SAPIEN TAVR Study Outcome Favorable
Edwards Lifesciences (EW) recent study provides insights into the actual performance of small Edwards valves and reaffirms the excellent outcomes…
Edwards Lifesciences stock upgraded to buy, PT lifted to $105 By Investing.com
Edwards Lifesciences stock upgraded to buy, PT lifted to $105…